Regeneron Pharmaceuticals, Inc. 0R2M
Market Closed
9 Sep, 15:30
$
1,147. 91
+10.93
+0.96%
$
98.44B Market Cap
24.52 P/E Ratio
0% Div Yield
302 Volume
42.79 Eps
$ 1,136.98
Previous Close Day Range
1,132 1,148.77
Year Range
771.9 1,210.92
| REGN Regeneron Pharmaceuticals Inc 31 Oct 2024 (45 Days) | | 11.83 Cons. EPS | - EPS |
| REGN Regeneron Pharmaceuticals Inc 1 Aug 2024 | | 10.61 Cons. EPS | 11.56 EPS |
| REGN Regeneron Pharmaceuticals Inc 2 May 2024 | | 10.09 Cons. EPS | 9.55 EPS |
| REGN Regeneron Pharmaceuticals Inc 2 Feb 2024 | | 10.73 Cons. EPS | 11.86 EPS |
| REGN Regeneron Pharmaceuticals Inc 2 Nov 2023 | | 10.72 Cons. EPS | 11.59 EPS |
| REGN Regeneron Pharmaceuticals Inc 4 Nov 2016 | | 2.71 Cons. EPS | 3.13 EPS |
| REGN Regeneron Pharmaceuticals Inc 4 Aug 2016 | | 2.65 Cons. EPS | 2.82 EPS |
| REGN Regeneron Pharmaceuticals Inc 5 May 2016 | | 2.58 Cons. EPS | 2.57 EPS |
| REGN Regeneron Pharmaceuticals Inc 9 Feb 2016 | | 3.36 Cons. EPS | 2.83 EPS |
| REGN Regeneron Pharmaceuticals Inc 4 Nov 2015 | | 3.2 Cons. EPS | 3.47 EPS |